3SBio (SSRX) Announces $6.25M Acquisition of Pegsiticase Rights from EnzymeRx
Tweet Send to a Friend
3SBio Inc. (Nasdaq: SSRX) announces the $6.25 million ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
